Pfizer And IBM Launch Ambitious 'Internet Of Things' For Parkinson's Research
Pfizer is betting big on the Internet of Things, or IoT, in medicine – that is, the connectivity of physical objects like medical devices to collect and exchange data – to boost Parkinson’s R&D and ultimately, to better inform care for patients.
To make this nebulous idea a reality, the pharmaceutical company is partnering with computer titan IBM to develop a system of sensors, mobile devices and machines that could deliver real-time, around-the-clock disease symptom monitoring of Parkinson’s patients to clinicians and researchers.
Also read: "Another #Wearable Device for Parkinson's #Pharma Research. This One Backed by MJFF"; http://sco.lt/6K4ZfN